mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |